HomeInsightsMarket Capitalization

Market Capitalization of Zydus Lifesciences Ltd

Market Capitalization of Zydus Lifesciences Ltd

stocks purchased

₹ 5.3 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

54.0 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

Market Cap

₹ 97997.13 crore

Last updated on: Dec 20, 2024

Key Highlights

  • The Market Cap of Zydus Lifesciences Ltd is ₹ 97997 crore as of 20 Dec 24 .
  • The Market Cap of Zydus Lifesciences Ltd changed from ₹ 35482 crore on March 2019 to ₹ 101151 crore on March 2024 . This represents a CAGR of 19.08% over 6 years.
  • The Latest Trading Price of Zydus Lifesciences Ltd is ₹ 973.9 as of 20 Dec 15:30 .
  • The Dividend Payouts of Zydus Lifesciences Ltd changed from ₹ 3.5 on Jul 25, 2019 to ₹ 3 on Jul 26, 2024 . This represents a CAGR of -2.54% over 6 years.

Historical Market Cap of Zydus Lifesciences Ltd

No data available

* All values are in crore

Company Fundamentals for Zydus Lifesciences Ltd

No data available

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

Share Price

₹ 973.9

-11.80 (-1.20%)

stock direction

Last updated on: Dec 20, 2024

Market Price of Zydus Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Zydus Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 2024973.9
19 Dec 2024985.7
18 Dec 2024979.1
17 Dec 2024969.5
16 Dec 2024988
13 Dec 2024978.35
12 Dec 2024975.65
11 Dec 2024986.3
10 Dec 2024974.7
09 Dec 2024982.9

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Zydus Lifesciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Zydus Lifesciences Ltd

No data available

No data available

Historical P/E Ratio of Zydus Lifesciences Ltd

No data available

* All values are in %

Historical Revenue of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Zydus Lifesciences Ltd

No data available

* All values are in

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
  • The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

Zydus Lifesciences Ltd News Hub

News

Zydus Life gets USFDA nod for Lidocaine and Prilocaine Cream USP

Lidocaine and Prilocaine Cream USP is indicated as a topical anaesthetic for use on normal...

Read more

19 Dec 2024 12:49

News

Zydus Lifesciences receives USFDA approval for Lidocaine and Prilocaine Cream

Zydus Lifesciences has received final approval from the United States Food and Drug Admini...

Read more

19 Dec 2024 14:58

News

Zydus Animal Health and Investment to divest its stake held in Mylan

Zydus Lifesciences announced that Zydus Animal Health and Investments, a wholly owned subs...

Read more

16 Dec 2024 12:50

News

Zydus Lifesciences Ltd spurts 1.03%, rises for third straight session

Zydus Lifesciences Ltd rose for a third straight session today. The stock is quoting at Rs...

Read more

03 Dec 2024 13:06

News

Zydus Lifesciences receives Rs 1.61-cr GST demand for FY 2017-18

The issue pertains to the Input Tax Credit (ITC) carried forward through the TRAN-1 form. ...

Read more

29 Nov 2024 12:04

News

Zydus Life Q2 PAT rises 14% YoY to Rs 911 cr

Revenue from operations grew 19.87% year on year (YoY) to Rs 5,237 crore in the quarter en...

Read more

12 Nov 2024 15:22

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Zydus Lifesciences Ltd Market Cap

What is the market cap of Zydus Lifesciences Ltd?

As of December 22, 2024, Zydus Lifesciences Ltd has a market capitalization of ₹97997.13, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Zydus Lifesciences Ltd's market capitalization?

Zydus Lifesciences Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Zydus Lifesciences Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Zydus Lifesciences Ltd's market capitalization change?

Zydus Lifesciences Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions